309 related articles for article (PubMed ID: 29429153)
1. Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells.
Fujiki H; Watanabe T; Sueoka E; Rawangkan A; Suganuma M
Mol Cells; 2018 Feb; 41(2):73-82. PubMed ID: 29429153
[TBL] [Abstract][Full Text] [Related]
2. Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate.
Fujiki H; Sueoka E; Rawangkan A; Suganuma M
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2401-2412. PubMed ID: 28942499
[TBL] [Abstract][Full Text] [Related]
3. Biophysical Approach to Mechanisms of Cancer Prevention and Treatment with Green Tea Catechins.
Suganuma M; Takahashi A; Watanabe T; Iida K; Matsuzaki T; Yoshikawa HY; Fujiki H
Molecules; 2016 Nov; 21(11):. PubMed ID: 27869750
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics.
Tang SN; Fu J; Nall D; Rodova M; Shankar S; Srivastava RK
Int J Cancer; 2012 Jul; 131(1):30-40. PubMed ID: 21796625
[TBL] [Abstract][Full Text] [Related]
5. Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds.
Fujiki H; Sueoka E; Watanabe T; Suganuma M
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1511-22. PubMed ID: 25544670
[TBL] [Abstract][Full Text] [Related]
6. Epigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines.
Lin CH; Shen YA; Hung PH; Yu YB; Chen YJ
BMC Complement Altern Med; 2012 Oct; 12():201. PubMed ID: 23110507
[TBL] [Abstract][Full Text] [Related]
7. Stiffening of Cancer Cell Membranes Is a Key Biophysical Mechanism of Primary and Tertiary Cancer Prevention with Green Tea Polyphenols.
Suganuma M; Rawangkan A; Wongsirisin P; Kobayashi N; Matsuzaki T; Yoshikawa HY; Watanabe T
Chem Pharm Bull (Tokyo); 2020; 68(12):1123-1130. PubMed ID: 33268644
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation.
Wubetu GY; Shimada M; Morine Y; Ikemoto T; Ishikawa D; Iwahashi S; Yamada S; Saito Y; Arakawa Y; Imura S
J Gastroenterol Hepatol; 2016 Jan; 31(1):256-64. PubMed ID: 26241688
[TBL] [Abstract][Full Text] [Related]
9. New cancer treatment strategy using combination of green tea catechins and anticancer drugs.
Suganuma M; Saha A; Fujiki H
Cancer Sci; 2011 Feb; 102(2):317-23. PubMed ID: 21199169
[TBL] [Abstract][Full Text] [Related]
10. (-)-Epigallocatechin-3-Gallate Inhibits Colorectal Cancer Stem Cells by Suppressing Wnt/β-Catenin Pathway.
Chen Y; Wang XQ; Zhang Q; Zhu JY; Li Y; Xie CF; Li XT; Wu JS; Geng SS; Zhong CY; Han HY
Nutrients; 2017 Jun; 9(6):. PubMed ID: 28587207
[TBL] [Abstract][Full Text] [Related]
11. Cancer Preventive Activities of Tea Catechins.
Yang CS; Wang H
Molecules; 2016 Dec; 21(12):. PubMed ID: 27941682
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.
Toden S; Tran HM; Tovar-Camargo OA; Okugawa Y; Goel A
Oncotarget; 2016 Mar; 7(13):16158-71. PubMed ID: 26930714
[TBL] [Abstract][Full Text] [Related]
13. Green tea catechins reduce invasive potential of human melanoma cells by targeting COX-2, PGE2 receptors and epithelial-to-mesenchymal transition.
Singh T; Katiyar SK
PLoS One; 2011; 6(10):e25224. PubMed ID: 22022384
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway.
Lee SH; Nam HJ; Kang HJ; Kwon HW; Lim YC
Eur J Cancer; 2013 Oct; 49(15):3210-8. PubMed ID: 23876835
[TBL] [Abstract][Full Text] [Related]
15. Challenging the effectiveness of green tea in primary and tertiary cancer prevention.
Fujiki H; Imai K; Nakachi K; Shimizu M; Moriwaki H; Suganuma M
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1259-70. PubMed ID: 22699930
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice.
Liu JD; Chen SH; Lin CL; Tsai SH; Liang YC
J Cell Biochem; 2001; 83(4):631-42. PubMed ID: 11746506
[TBL] [Abstract][Full Text] [Related]
17. Wnt/β-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells.
Zhu J; Jiang Y; Yang X; Wang S; Xie C; Li X; Li Y; Chen Y; Wang X; Meng Y; Zhu M; Wu R; Huang C; Ma X; Geng S; Wu J; Zhong C
Biochem Biophys Res Commun; 2017 Jan; 482(1):15-21. PubMed ID: 27836540
[TBL] [Abstract][Full Text] [Related]
18. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review.
Gan RY; Li HB; Sui ZQ; Corke H
Crit Rev Food Sci Nutr; 2018 Apr; 58(6):924-941. PubMed ID: 27645804
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells.
Mineva ND; Paulson KE; Naber SP; Yee AS; Sonenshein GE
PLoS One; 2013; 8(9):e73464. PubMed ID: 24039951
[TBL] [Abstract][Full Text] [Related]
20. Green tea polyphenol sensing.
Tachibana H
Proc Jpn Acad Ser B Phys Biol Sci; 2011; 87(3):66-80. PubMed ID: 21422740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
